Composite Endpoints for Clinical Trials
- 1 January 2007
- journal article
- Published by Springer Science and Business Media LLC in International Journal of Pharmaceutical Medicine
- Vol. 21 (3), 187-198
- https://doi.org/10.2165/00124363-200721030-00001
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Composite and surrogate outcomes in randomised controlled trialsBMJ, 2007
- Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trialsBMJ, 2007
- The DREAM trialThe Lancet, 2006
- The DREAM trialThe Lancet, 2006
- The DREAM trialThe Lancet, 2006
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Considerations in choice of a clinical endpoint for AIDS clinical trialsStatistics in Medicine, 1994
- Exercise Testing as Outcome in Congestive Heart Failure TrialsDrugs, 1994